Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Clinical trial NCT01776606 · COMPLETED
Trial details
- NCT number
- NCT01776606
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.